New hope for kids with rare epilepsy: drug trial targets seizures
NCT ID NCT05818553
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study tests an experimental drug called PRAX-562 in 77 children with rare genetic epilepsies (SCN2A or SCN8A) that cause severe seizures starting in infancy. The goal is to see if the drug is safe and can reduce monthly motor seizures. The trial has a double-blind phase followed by an open-label extension where all children receive the drug.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCN2A ENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Praxis Research Site
Atlanta, Georgia, 30329, United States
-
Praxis Research Site
Chicago, Illinois, 60611, United States
-
Praxis Research Site
Minneapolis, Minnesota, 55113, United States
-
Praxis Research Site
Hackensack, New Jersey, 07601, United States
-
Praxis Research Site
Tel Litwinsky, 52621, Israel
-
Praxis Research Site
Madrid, 28034, Spain
-
Praxis Research Site
Glasgow, G51 4TF, United Kingdom
-
Praxis Research Site
London, WC1N 3BH, United Kingdom
Conditions
Explore the condition pages connected to this study.